End-to-end R&D, from first protocol to factory floor.

Flexible, on-demand capacity

No rigid multi-year lock-ins. Scale your research capacity up or down with your funding cycles, market demands or milestones, from simple analytical testing and validation to multi-phase synthetic biology discovery.

IP protection and data stewardship

From the moment we sign a Non-Disclosure Agreement, every discovery, optimised protocol, metabolic pathway and chemical structure developed in your project remains 100% yours. We enforce strict digital data isolation and physical access security.

Data-driven, regulatory-compliant execution

We deliver comprehensive, audit-ready data packages, not ambiguous lab notes. Every milestone is continuously validated and structured to international regulatory baselines, ready for market inspections, patent applications or manufacturing scale-up.

Built around commercial realities

Every protocol is engineered backwards from your commercial goal, accounting for facility constraints, regulatory targets, raw material budgets and production scale, whether it is a novel extraction method for cosmetics or a fermentation pathway for alternative proteins.

Standardised for reproducibility

We address the reproducibility problem with precise concentrations, temperature profiles, time intervals and environmental parameters, delivering protocols that give identical, high-purity results regardless of technician or facility.

Audit-ready compliance and tech transfer

Each workflow comes with step-by-step documentation, QC validation metrics and analytical benchmarks aligned with frameworks such as GMP and ISO, plus full technical transfer support for your teams.

De-risking scale-up

Moving from a 1-litre flask to a 10,000-litre bioreactor introduces new physical variables. We treat scale-up as precise engineering, using intermediate pilot-scale models to find and remove bottlenecks.

Yield and cost optimisation

We audit every variable to maximise space-time yield and purity while lowering operating costs, targeting the lowest possible cost of goods sold for healthy margins.

Technical transfer and factory integration

Every process is documented with SOPs, mass and energy balances and critical process parameter dashboards. We support your CMO or engineering team until the process runs smoothly on your production floor.

Predictive modelling and simulation

We use computational fluid dynamics and AI-based predictive modelling to simulate large-scale conditions before a pilot bioreactor is switched on, saving months and raw material costs.

Ideation and formulation

We define the target product profile with your team and evaluate ingredient compatibility, stability, bioavailability and sensory profile from day one, whether it is a clean-beauty serum, a functional nutraceutical beverage or a crop protection agent.

Prototype to pilot, faster

Agile R&D loops let us iterate physical prototypes quickly and stress-test them against real consumer and manufacturing conditions, so a successful lab formulation moves smoothly into a high-yielding pilot run.

Commercialisation and tech transfer

We help source industrial-grade raw materials, check packaging compatibility with bio-actives and train factory teams, staying with you until your product is retail-ready.

Ultra-pure nucleic acid extraction and stability testing

The integrity of your entire translational study hinges on the quality of your initial samples. We deploy high-throughput, standardised extraction protocols for the isolation of ultra-pure DNA, RNA and cell-free DNA (cfDNA) from complex biological matrices, including whole blood, plasma, tissues, saliva and biopsies. Our workflows eliminate cross-contamination and enzymatic inhibitors, so every sample is stabilised and optimised for downstream molecular analysis.

High-precision polymerase chain reaction (PCR) workflows

We provide comprehensive quantitative and qualitative validation through advanced amplification technologies. Our capabilities include quantitative real-time PCR (qPCR) for precise gene expression analysis and digital droplet PCR (ddPCR) for the absolute quantification of low-abundance targets, rare mutations or viral loads. We custom-design and validate primer and probe sets, so your clinical and translational assays achieve maximum sensitivity and specificity.

Next-generation sequencing (NGS) and library preparation support

We remove the technical friction from your genomic discovery pipelines. Our team provides end-to-end library preparation and sequencing support tailored to translational and biomarker focus areas. Whether you are running targeted gene panels, whole-exome sequencing (WES) or transcriptome profiling (RNA-Seq), we transform raw clinical samples into high-density digital sequence data, fully prepared for bioinformatic alignment.

Proteomic and advanced protein profiling

We complement your translational studies with rigorous protein profiling services, including Western blotting, high-sensitivity enzyme-linked immunosorbent assays (ELISA) and multiplex protein arrays. By mapping protein expression, post-translational modifications and binding interactions, we deliver the phenotypic evidence required to confirm drug mechanisms of action and validate candidate biomarkers.

Comprehensive industrial microbiology and purity assays

Microbial enumeration and identification

High-accuracy quantitative testing for Total Aerobic Microbial Count (TAMC) and Total Combined Yeasts and Moulds Count (TYMC) across raw materials, intermediates and final formulations.

Absence of specified microorganisms

Strict screening for objectionable pathogens, including E. coli, S. aureus, P. aeruginosa and Salmonella, tailored to industry-specific safety mandates.

Antimicrobial effectiveness testing (AET)

Evaluation of preservative systems within formulations to ensure long-term safety against contamination from multi-dose use, aligned with global pharmacopoeia standards.

ICH-compliant stability and degradation studies

Photostability and forced degradation

Stress-testing formulations under intense light, thermal variation, extreme pH and oxidative environments to systematically identify degradation pathways and impurities.

Accelerated and real-time storage tracking

Environmental chamber testing under ICH-defined climate zones (Zone I–IV) to map real-time shelf life, ingredient recovery, physical separation and molecular shifts.

Container-closure integrity

Assessing how packaging interactions affect active-ingredient stability, preventing moisture permeation, leaching or oxygen degradation.

Advanced formulation analytics and bioassays

Active ingredient fingerprinting

Using high-performance liquid chromatography (HPLC), spectrophotometry and enzymatic assays to verify the precise concentration and potency of your bio-actives over time.

Physical and rheological profiling

Monitoring structural variations, including viscosity shifts, pH drift, phase separation, colour fastness and dissolution rates, across extended storage life cycles.

Biocompatibility and safety screening

In vitro evaluation of formulation toxicity, irritation metrics and raw material compatibility to de-risk downstream clinical or dermatological testing.

Pathogen kinetics and antimicrobial efficacy testing

In vitro susceptibility profiling

Rigorous Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays to profile the potency of novel antimicrobial agents, small molecules and peptides.

Time-kill and synergy assays

Mapping the exact death-rate kinetics of bacterial and fungal targets over time, including combination testing to identify synergistic therapeutic interactions.

Biofilm disruption analytics

Evaluating the ability of novel compounds to penetrate, disrupt and eradicate resilient microbial biofilms, a critical benchmark for chronic infectious disease therapeutics.

High-sensitivity humoral immune profiling

Multiplexed and quantitative ELISA

High-affinity enzyme-linked immunosorbent assays to accurately quantify antigen-specific IgG, IgM and IgA antibody titres in serum, plasma and mucosal secretions.

Avidity and binding affinity assays

Measuring the structural strength and binding maturity of vaccine-induced or therapeutic antibodies against specific viral or bacterial target proteins.

Neutralisation and inhibition kinetics

Functional assays that evaluate the ability of antibodies to physically block pathogen-receptor interactions, delivering critical data on protective immunity.

Cellular immunology and functional immune monitoring

Immune cell proliferation profiles

Quantifying lymphocyte and T-cell expansion following exposure to specific target antigens or vaccine candidates.

Cytokine and chemokine secretion profiling

Highly sensitive multiplex immunoassay platforms or Western blotting to map systemic immune signalling pathways, cytokine storms and inflammatory cascades.

Phenotypic and biomarker characterisation

Evaluating cell-surface markers and cellular activation states to complement translational studies and de-risk host-pathogen interaction models.

Phytochemical profiling

We perform detailed analysis of the bioactive compounds in herbal and natural products. This includes qualitative and quantitative screening of alkaloids, flavonoids, tannins, saponins, phenolics and other secondary metabolites that define therapeutic potential and product uniqueness.

Antioxidant assays

Using validated methods such as DPPH, ABTS and FRAP, we measure radical scavenging activity and express results in standard equivalents as required. This provides a benchmark for antioxidant strength, supporting nutraceutical, cosmetic and pharma applications.

Microbial limits testing

We ensure product safety and compliance by testing for microbial contamination, including total viable count, yeast and mould, and pathogens such as E. coli and Salmonella sp.

Raw material testing

Impurity profiling and limit tests

High-sensitivity detection of heavy metals, residual solvents and organic impurities, so raw inputs meet strict regulatory baselines before entering production.

Physicochemical characterisation

Evaluation of physical properties, including melting point, particle size distribution, solubility and optical rotation, for seamless manufacturing integration.

Microbial testing

Bioburden enumeration and selective pathogen isolation, with quantitative microbial testing and charts.

Finished product testing and release analytics

Assay and potency validation

High-performance liquid chromatography (HPLC) and spectrophotometry to confirm exact active-ingredient concentrations in finished dosages.

Microbial testing

Bioburden enumeration and sterility testing of finished products.

Advanced moisture analysis and solid-state characterisation

Karl Fischer titration

High-precision volumetric and coulometric Karl Fischer titration for the absolute quantification of trace moisture in hydrophilic and hydrophobic matrices.

Loss on drying (LOD)

Determining volatile matter content under precise thermal regulation so materials remain within strict stability thresholds.

Stability safeguarding

Monitoring moisture dynamics to prevent active-ingredient hydrolysis, crystal lattice transitions and physical degradation over the product lifecycle.

Microbiological limits and bioburden screening

Quantitative microbial enumeration

Precise testing for Total Aerobic Microbial Count (TAMC) and Total Combined Yeasts and Moulds Count (TYMC) to verify products remain within safe biological thresholds.

Pathogen screening

Rigorous exclusion testing for specified objectionable microorganisms, confirming the absence of E. coli, Salmonella, S. aureus and P. aeruginosa.

Environmental and sterility baseline mapping

Evaluating the microbial cleanliness of materials and formulations to de-risk downstream industrial production and clinical trial pipelines.

Rigorous industrial and experimental biostatistics

A breakthrough needs mathematical proof to survive regulatory scrutiny and mass scale-up. We apply high-level biostatistical models to your laboratory and pilot-plant datasets. From analysis of variance (ANOVA) and multivariate regression to survival analysis and dose-response curves, we validate your findings with statistical confidence. We eliminate false positives and make sure your experimental protocols are reproducible, predictable and robust.

Explainable analytics for regulatory compliance

In modern bioscience, black-box algorithms are a serious liability during regulatory audits. We enforce strict explainability across all our models and analytical reports. Every chart, p-value, confidence interval and predictive metric is transparent, interpretable and clearly documented. This clarity gives global regulators (such as the FDA, EMA or EFSA) and corporate investors immediate confidence, paving a smoother path to market clearance.

High-throughput genomics and next-generation sequencing (NGS)

Raw sequencing data is a liability without proper processing. Our bioinformatics engine cleans, aligns and interprets dense datasets from whole-genome sequencing (WGS), RNA-Seq and single-cell transcriptomics. We identify critical genetic markers, trace metabolic pathways and map target expression.

Advanced proteomics and structural biology

Proteins are the workhorses of industrial biotechnology. We use state-of-the-art computational tools, including advanced structural modelling and predictive folding algorithms, to map 3D protein shapes and molecular dynamics. We simulate how enzymes interact with substrates, engineer highly stable biocatalysts for manufacturing and predict antibody-antigen binding affinities. This lets you design high-performance bio-actives for cosmetics and functional foods before a single wet-lab resource is used.

Metabolic pathway engineering and in silico simulation

We view biological cells as living factories. Our computational biology workflows build detailed digital models of cellular networks. By simulating how metabolic pathways behave under varied conditions, we can predict where cellular bottlenecks will occur. Our teams can then design gene knockouts, optimise nutrient utilisation and boost fermentation yields in a virtual environment first, saving months of laboratory trial and error.

Submission-ready peer-reviewed publications

Securing a place in top-tier, high-impact journals demands flawless data presentation and a compelling narrative. Our medical and scientific writers translate your raw laboratory records into publication-ready manuscripts. We handle everything from abstract drafting and literature reviews to methodology and statistical discussion, meeting the formatting and ethical standards of your target journals.

Rigorous regulatory and compliance dossiers

Moving from an R&D breakthrough to market clearance requires extensive technical documentation. We build robust regulatory submissions for global bodies, including the FDA, EMA, EFSA and local authorities. Our team compiles Investigational New Drug (IND) applications, New Drug Applications (NDA), cosmetic safety assessments and agritech environmental impact reports, mapping every data point to compliance guidelines to reduce the risk of delays or rejection.

Data clarity and visual analytics

Scientific writing is not just about words. It is about how clearly the data tells its story. Driven by our data-at-the-core philosophy, we turn complex genomics and proteomics data into clear, useful charts, schemas and matrices, making it easy for peer reviewers and auditors to grasp the innovation, safety margins and commercial validity of your protocols.

Transparency and explainable science

In modern biotechnology, ambiguity is the enemy of approval. We open up advanced methods, such as machine-learning pathways or metabolic engineering steps, so investors, compliance officers and academic peers understand exactly why and how an outcome was achieved. This transparency builds market trust, protects your competitive edge and accelerates third-party validation.

Corporate upskilling for industry teams

Tailored programmes that bring your R&D or production staff up to date on frontier protocols, compliance changes and automated laboratory workflows.

Technical enablement for biotech startups

Intensive training built around your venture’s target product profile, covering scale-up, space-time yield optimisation and data security to protect your IP from day one.

PhD assistance programme

• Synopsis and proposal writing: clear, novel hypotheses and robust methods.
• Data analysis and interpretation: biostatistics, bioinformatics tools and data presentation.
• Manuscript editing and peer-review prep for PubMed, Scopus and WoS-indexed journals.
• Thesis structuring and defence prep, including mock viva-voce sessions.

College & university · B.Sc, M.Sc, B.Tech, M.Tech

• Curriculum and project guidance for final-year projects and industrial dissertations.
• Higher education mapping towards M.Sc, M.Tech or PhD programmes worldwide.
• Skill gap analysis for the wet-lab and computational skills that stand out.
• Entrance exam strategy for competitive bioscience exams and fellowships.

School counselling · Classes 10–12

• Stream and subject selection, including PCMB or vocational biotech.
• Profile building through summer camps, science fairs and foundation courses.
• Emerging fields such as genetic engineering, astrobiology and synthetic biology.